ALBANY, N.Y., March 21, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that it will report its fiscal 2012 third quarter financial results on Wednesday, April 4, 2012, after the close of the U.S. financial markets.
